This website uses cookies to ensure you have the best user experience. By continuing to use this website, you consent to our use of cookies. For more information, read our privacy policy.
This is a test.
Precision medicine for patients with co-existent ovarian and endometrial cancer: the COMPARE trial
This is a test.
Prevalence and Experience of Traumatic Stress in Patients with Newly Diagnosed and Recurrent Advanced Ovarian Cancer
This is a test.
Effect of intravenous iron infusion on the prevention and treatment of anemia in ovarian cancer
This is a test.
Using patient-derived models and drug sensitivity testing to guide personalized medicine: a proof-of-concept trial
This is a test.
ES2 trial: combining a PARP inhibitor and apoptosis sensitizer
This is a test.
Tumour testing and ovarian cancer drug prediction program
This is a test.
Phase II clinical trial of CX5461 at the time of disease progression on a PARP inhibitor
This is a test.
CHARM Early Detection Clinical Trial
This is a test.
Re-VOLVE trial: using genomics to make treatment decisions after a PARP inhibitor
